Systematic elucidation of calcineurin phosphatase signaling in humans

系统阐明人类钙调神经磷酸酶信号传导

基本信息

  • 批准号:
    10371219
  • 负责人:
  • 金额:
    $ 54.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

Project Summary All eukaryotes use phosphorylation-based signaling networks, composed of protein kinases and phosphatases, to regulate cellular processes. While global information about kinase signaling has exploded, knowledge of phosphatases has lagged behind. The lack of systematic, unbiased approaches to analyze phosphatase signaling leaves a major gap in our understanding of cellular regulatory networks. For >25 years, my research on calcineurin, the conserved Ca2+/calmodulin-regulated phosphatase, in S. cerevisiae and humans has directly addressed this issue. Calcineurin is ubiquitously expressed and plays critical regulatory roles in the cardiovascular, nervous and immune systems (1); however, only ~70 proteins are currently established as calcineurin substrates (2). Calcineurin dephosphorylates the Nuclear Factor of Activated T-cells (NFAT) transcription factors to activate the adaptive immune response (3), and calcineurin inhibitors, FK506 and cyclosporin A, are commonly prescribed as immunosuppressants (4). However, these drugs cause unwanted effects, including hypertension, diabetes, and seizures by inhibiting calcineurin in non-immune tissues (5), highlighting the need to map human calcineurin signaling pathways systematically. My work elucidates calcineurin signaling through novel approaches based on the discovery of short linear motifs (SLiMs): short degenerate peptide sequences found within regions of intrinsic disorder that determine specific, low- affinity interactions that are essential for signaling (6). Using experimental and in silico SLiM-based methods, we recently defined the human calcineurin signaling network (2). This work uncovered conserved regulation of nuclear pore complexes by calcineurin and showed unexpected calcineurin proximity to centrosomes (2). Future efforts will elucidate Ca2+ and calcineurin signaling at these compartments using a combination of methods that include phosphoproteomics and proximity labeling with faster-labeling biotin ligases (miniTurbo (33), Split TurboID). Fluorescent sensors will be used to probe Ca2+ signals at these locations in vivo. Calcineurin functions at membranes will be analyzed by focusing on CNb1, a little-studied isoform with distinct localization and regulation conferred by its unique, lipidated C-terminal sequences (10). Regulation of CNb1 activity via dynamic palmitoylation will be examined, and CNb1-specific signaling pathways, including regulation of PI4P synthesis, will be established to achieve a comprehensive and mechanistic understanding of this enzyme. Finally, the novel technology, MRBLE-PEP (Microspheres Ratiometric Barcode Lanthenide Encoding coupled to PEPtides) (11), will be developed for quantitative analysis and discovery of SLiMs. Overall this research aims to map human calcineurin signaling pathways systematically and to advance our understanding of SLiM-based signaling more broadly.
项目摘要 所有真核生物都使用基于磷酸化的信号网络,由蛋白激酶和 磷酸酶来调节细胞过程。虽然关于激酶信号传导的全球信息 爆炸,磷酸酶的知识已经落后。缺乏系统、公正的方法 分析磷酸酶信号留下了一个重大差距,在我们的理解细胞调控 网络. 25年来,我对钙调神经磷酸酶的研究,保守的Ca 2 +/钙调素调节, 磷酸酶,在S.酿酒酵母和人类已经直接解决了这个问题。钙调神经磷酸酶普遍存在于 在心血管、神经和免疫系统中表达并发挥重要的调节作用(1); 然而,目前只有约70种蛋白质被确定为钙调磷酸酶底物(2)。钙调 使活化T细胞核因子(NFAT)转录因子去磷酸化,以活化 适应性免疫反应(3)和钙调磷酸酶抑制剂,FK 506和环孢菌素A,通常是 作为免疫抑制剂(4)。然而,这些药物会引起不良反应,包括 高血压、糖尿病和癫痫发作通过抑制非免疫组织中的钙调神经磷酸酶(5),突出了 需要系统地绘制人类钙调神经磷酸酶信号通路。我的工作阐明了钙调神经磷酸酶 通过基于发现短线性基序(SLiM)的新方法进行信号传导:短 在决定特异性、低- 对于信号传导至关重要的亲和相互作用(6)。使用实验和基于SLiM的计算机模拟 方法,我们最近定义了人类钙调磷酸酶信号网络(2)。这项工作揭示了 钙调神经磷酸酶对核孔复合物的保守调节,并显示出意想不到的钙调神经磷酸酶 接近中心体(2)。未来的努力将阐明这些细胞中的Ca 2+和钙调神经磷酸酶信号传导。 使用包括磷酸化蛋白质组学和邻近标记的方法的组合, 用更快标记的生物素连接酶(miniTurbo(33),Split TurboID)。荧光传感器将用于 探针Ca 2+信号在这些位置在体内。钙调神经磷酸酶在膜上的功能将通过 专注于CNb 1,一种很少研究的同种型,具有独特的定位和调控, 脂化C-末端序列(10)。通过动态棕榈酰化调节CNb 1活性将是 检查,CNb 1特异性信号通路,包括PI 4P合成的调节,将被 建立了一个全面的和机械的理解这种酶。最后 新技术,MRBLE-PEP(微球比例条形码镧系元素编码耦合到 PEPtides)(11)将被开发用于SLiM的定量分析和发现。总的来说,这项研究 旨在系统地绘制人类钙调神经磷酸酶信号通路, 基于SLiM的信令更广泛。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martha S. Cyert其他文献

Martha S. Cyert的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Martha S. Cyert', 18)}}的其他基金

Systematic elucidation of calcineurin phosphatase signaling in humans
系统阐明人类钙调神经磷酸酶信号传导
  • 批准号:
    10596473
  • 财政年份:
    2020
  • 资助金额:
    $ 54.91万
  • 项目类别:
Systematic elucidation of calcineurin phosphatase signaling in humans
系统阐明人类钙调神经磷酸酶信号传导
  • 批准号:
    10818737
  • 财政年份:
    2020
  • 资助金额:
    $ 54.91万
  • 项目类别:
Discovering the mechanisms and functions of signaling by the calcineurin beta1 isoform
发现钙调神经磷酸酶 beta1 亚型的信号传导机制和功能
  • 批准号:
    9921418
  • 财政年份:
    2019
  • 资助金额:
    $ 54.91万
  • 项目类别:
Identifying The Human Calcineurin Signaling Network
识别人类钙调神经磷酸酶信号网络
  • 批准号:
    9276716
  • 财政年份:
    2016
  • 资助金额:
    $ 54.91万
  • 项目类别:
HPH1 AND HPH2 ARE NOVEL COMPONENTS OF THE SEC63/SEC62 COMPLEX
HPH1 和 HPH2 是 SEC63/SEC62 复合体的新颖成分
  • 批准号:
    8365855
  • 财政年份:
    2011
  • 资助金额:
    $ 54.91万
  • 项目类别:
Role of Ca2+/Calcineurin Signaling in S.Cerevisiae
Ca2/钙调磷酸酶信号在酿酒酵母中的作用
  • 批准号:
    7930987
  • 财政年份:
    2009
  • 资助金额:
    $ 54.91万
  • 项目类别:
DEPHOSPHORYLATION OF CRZ1 BY CALCINEURIN
钙调磷酸酶对 CRZ1 的去磷酸化
  • 批准号:
    6979543
  • 财政年份:
    2004
  • 资助金额:
    $ 54.91万
  • 项目类别:
ROLE OF PKC1
PKC1 的作用
  • 批准号:
    6979547
  • 财政年份:
    2004
  • 资助金额:
    $ 54.91万
  • 项目类别:
PROTEIN COMPLEXES CONTAINING CALCINEURIN AND CRZ1P
含有钙调磷酸酶和 CRZ1P 的蛋白质复合物
  • 批准号:
    6979690
  • 财政年份:
    2004
  • 资助金额:
    $ 54.91万
  • 项目类别:
CA2+ AND CALICNEURIN DEPENDENT TWO-HYBRID INTERACTIONS
CA2 和钙调磷酸酶依赖性双杂交相互作用
  • 批准号:
    6979679
  • 财政年份:
    2004
  • 资助金额:
    $ 54.91万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 54.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 54.91万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 54.91万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 54.91万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 54.91万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 54.91万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 54.91万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 54.91万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 54.91万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 54.91万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了